Results 131 to 140 of about 4,083,225 (263)

Diabetes Incidence According to Statin Intensity Regimen, Body Mass Index, and Cardiorespiratory Fitness

open access: yes
OBJECTIVE: To evaluate the association between statin therapy, cardiorespiratory fitness (CRF), body mass index (BMI), and type 2 diabetes mellitus (T2DM).
Myers, Jonathan   +10 more
core   +1 more source

Is High‐Intensity Statin Therapy Associated With Lower Statin Adherence Compared With Low‐ to Moderate‐Intensity Statin Therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines

open access: yes, 2014
Background: The recent cholesterol guideline recommends high-intensity statins in cardiovascular disease (CVD) patients. High-intensity statins are associated with more frequent side effects.
Petersen, Laura A   +11 more
core   +1 more source

Risk of breast cancer death by amount, years and intensity of post-diagnostic statin use as compared to non-users.

open access: yes, 2014
Statin users limited to new post-diagnostic users only.aCalculated with Cox regression model adjusted for age, tumor stage and morphology and treatment selection.DDD = Defined Daily Dose.Risk of breast cancer death by amount, years and intensity of post ...
Kala Visvanathan (122391)   +4 more
core   +1 more source

Statin Use and the Risk for Incident Diabetes Mellitus in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Population-Based Retrospective Cohort Study in Taiwan

open access: yes, 2017
Objectives: The purpose of this study was to examine the association between statin use by individuals and the risk for incident diabetes mellitus in patients with acute coronary syndrome (ACS) following per cutaneous coronary intervention (PCI ...
林慧玲;蕭斐元;沈麗娟   +1 more
core   +1 more source

Clinical Translation of Patient‐Derived Organoids: Perspectives for Personalized Therapy in Cancer

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT Patient‐derived organoids (PDO) are accelerating precision medicine. These biological platforms allow for the autologous in vitro expansion of material from cancer patients in a considerably short period of time. These three‐dimensional models can faithfully recapitulate aspects of tissue heterogeneity, architecture, and relevant cellular ...
Haiyan Yue   +6 more
wiley   +1 more source

Combination therapy with moderate-intensity statins and ezetimibe and risk of incident PCI/CABG in atherosclerotic cardiovascular disease: a propensity-matched cohort studyResearch in context

open access: yesThe Lancet Regional Health. Western Pacific
Summary: Background: Combination therapy with moderate-intensity statins and ezetimibe has demonstrated advantages over high-intensity statin monotherapy for several cardiovascular outcomes.
Haonan He   +8 more
doaj   +1 more source

TRIM31–LOX‐1 Axis: A Novel Therapeutic Frontier in Atherosclerosis

open access: yesiNew Medicine, EarlyView.
ABSTRACT Atherosclerosis, driven by a vicious cycle of lipid accumulation and chronic inflammation, underlies most cardiovascular diseases. Macrophages exacerbate this process by internalizing oxidized low‐density lipoprotein (oxLDL), forming foam cells, and releasing inflammatory mediators. A recent study published in Circulation identified the TRIM31–
Qian Zhang, Cheng Xue Qin
wiley   +1 more source

Additional file 4: of Statin drugs to reduce breast cancer recurrence and mortality

open access: yes, 2018
High-, moderate-, and low-intensity statin therapy. Statin dosages that achieve plasma reductions in LDL-C of  50% (high-intensity), as tested in randomized control trials (RCTs) and reported in the 2013 American College of Cardiology (ACC) and American ...
Colin Beckwitt (4593115)   +3 more
core   +1 more source

Research Progress of Berberine in Kidney Disease: Targeting Mitochondria and Ferroptosis

open access: yesiNew Medicine, EarlyView.
This figure illustrates the model‐specific renoprotective mechanisms of berberine (BBR) across three major kidney diseases. From left to right, the diagram shows that BBR targets distinct core pathways depending on the pathological context: in diabetic nephropathy (DN), BBR activates AMPK to improve mitochondrial energy metabolism; in acute kidney ...
Liuqing Wang   +3 more
wiley   +1 more source

Effect of Ezetimibe Added to High-intensity Statin Therapy in Patients with Hypercholesterolemia: A Meta-Analysis

open access: yes, 2018
Background: It is unknown whether the conclusion of the IMPROVE-IT trial can be extrapolated into patients taking high intensity statin plus ezetimibe.
Ling, Hua   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy